Organon & Co. (OGN)
8.10
+0.58
(+7.71%)
USD |
NYSE |
Feb 20, 16:00
8.12
+0.02
(+0.25%)
After-Hours: 20:00
Organon EPS Diluted (Quarterly) : -0.7879 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 1.191 |
| Amphastar Pharmaceuticals, Inc. | 0.3639 |
| Plus Therapeutics, Inc. | -0.0412 |
| Geron Corp. | -0.0276 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -205.00M |
| Revenue (Quarterly) | 1.507B |
| Total Expenses (Quarterly) | 1.712B |
| Enterprise Value | 10.26B |
| Gross Profit Margin (Quarterly) | 49.17% |
| Profit Margin (Quarterly) | -13.60% |
| Earnings Yield | 8.85% |
| Operating Earnings Yield | 58.10% |
| Normalized Earnings Yield | 22.29 |